These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. WOX1 is essential for tumor necrosis factor-, UV light-, staurosporine-, and p53-mediated cell death, and its tyrosine 33-phosphorylated form binds and stabilizes serine 46-phosphorylated p53. Chang NS; Doherty J; Ensign A; Schultz L; Hsu LJ; Hong Q J Biol Chem; 2005 Dec; 280(52):43100-8. PubMed ID: 16219768 [TBL] [Abstract][Full Text] [Related]
4. WW domain-containing oxidoreductase promotes neuronal differentiation via negative regulation of glycogen synthase kinase 3β. Wang HY; Juo LI; Lin YT; Hsiao M; Lin JT; Tsai CH; Tzeng YH; Chuang YC; Chang NS; Yang CN; Lu PJ Cell Death Differ; 2012 Jun; 19(6):1049-59. PubMed ID: 22193544 [TBL] [Abstract][Full Text] [Related]
5. Active c-jun N-terminal kinase induces caspase cleavage of tau and additional phosphorylation by GSK-3beta is required for tau aggregation. Sahara N; Murayama M; Lee B; Park JM; Lagalwar S; Binder LI; Takashima A Eur J Neurosci; 2008 Jun; 27(11):2897-906. PubMed ID: 18540881 [TBL] [Abstract][Full Text] [Related]
6. 17beta-estradiol attenuates glycogen synthase kinase-3beta activation and tau hyperphosphorylation in Akt-independent manner. Shi HR; Zhu LQ; Wang SH; Liu XA; Tian Q; Zhang Q; Wang Q; Wang JZ J Neural Transm (Vienna); 2008 Jun; 115(6):879-88. PubMed ID: 18217188 [TBL] [Abstract][Full Text] [Related]
7. Mechanism of zinc-induced phosphorylation of p70 S6 kinase and glycogen synthase kinase 3beta in SH-SY5Y neuroblastoma cells. An WL; Bjorkdahl C; Liu R; Cowburn RF; Winblad B; Pei JJ J Neurochem; 2005 Mar; 92(5):1104-15. PubMed ID: 15715661 [TBL] [Abstract][Full Text] [Related]
8. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration. Ferrer I; Barrachina M; Puig B Acta Neuropathol; 2002 Dec; 104(6):583-91. PubMed ID: 12410379 [TBL] [Abstract][Full Text] [Related]
9. Bip enhanced the association of GSK-3β with tau during ER stress both in vivo and in vitro. Liu ZC; Fu ZQ; Song J; Zhang JY; Wei YP; Chu J; Han L; Qu N; Wang JZ; Tian Q J Alzheimers Dis; 2012; 29(4):727-40. PubMed ID: 22460328 [TBL] [Abstract][Full Text] [Related]
10. The active form of glycogen synthase kinase-3beta is associated with granulovacuolar degeneration in neurons in Alzheimer's disease. Leroy K; Boutajangout A; Authelet M; Woodgett JR; Anderton BH; Brion JP Acta Neuropathol; 2002 Feb; 103(2):91-9. PubMed ID: 11810173 [TBL] [Abstract][Full Text] [Related]
11. MPP+-induced neuronal death in rats involves tyrosine 33 phosphorylation of WW domain-containing oxidoreductase WOX1. Lo CP; Hsu LJ; Li MY; Hsu SY; Chuang JI; Tsai MS; Lin SR; Chang NS; Chen ST Eur J Neurosci; 2008 Apr; 27(7):1634-46. PubMed ID: 18371080 [TBL] [Abstract][Full Text] [Related]
12. 17beta-Estradiol upregulates and activates WOX1/WWOXv1 and WOX2/WWOXv2 in vitro: potential role in cancerous progression of breast and prostate to a premetastatic state in vivo. Chang NS; Schultz L; Hsu LJ; Lewis J; Su M; Sze CI Oncogene; 2005 Jan; 24(4):714-23. PubMed ID: 15580310 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of glycogen synthase kinase-3 reverses tau hyperphosphorylation induced by Pin1 down-regulation. Xiong YS; Wang DL; Tan L; Wang X; Chen LM; Gong CX; Wang JZ; Zhu LQ CNS Neurol Disord Drug Targets; 2013 May; 12(3):436-43. PubMed ID: 23469846 [TBL] [Abstract][Full Text] [Related]
14. Stimulation of EphB2 attenuates tau phosphorylation through PI3K/Akt-mediated inactivation of glycogen synthase kinase-3β. Jiang J; Wang ZH; Qu M; Gao D; Liu XP; Zhu LQ; Wang JZ Sci Rep; 2015 Jun; 5():11765. PubMed ID: 26119563 [TBL] [Abstract][Full Text] [Related]
15. Increased level of active GSK-3beta in Alzheimer's disease and accumulation in argyrophilic grains and in neurones at different stages of neurofibrillary degeneration. Leroy K; Yilmaz Z; Brion JP Neuropathol Appl Neurobiol; 2007 Feb; 33(1):43-55. PubMed ID: 17239007 [TBL] [Abstract][Full Text] [Related]
17. Modulation of tau phosphorylation by the kinase PKR: implications in Alzheimer's disease. Bose A; Mouton-Liger F; Paquet C; Mazot P; Vigny M; Gray F; Hugon J Brain Pathol; 2011 Mar; 21(2):189-200. PubMed ID: 21029237 [TBL] [Abstract][Full Text] [Related]
18. SLM, a novel carbazole-based fluorophore attenuates okadaic acid-induced tau hyperphosphorylation via down-regulating GSK-3β activity in SH-SY5Y cells. Wu X; Kosaraju J; Tam KY Eur J Pharm Sci; 2017 Dec; 110():101-108. PubMed ID: 28359686 [TBL] [Abstract][Full Text] [Related]
19. The participation of insulin-like growth factor-binding protein 3 released by astrocytes in the pathology of Alzheimer's disease. Watanabe K; Uemura K; Asada M; Maesako M; Akiyama H; Shimohama S; Takahashi R; Kinoshita A Mol Brain; 2015 Dec; 8(1):82. PubMed ID: 26637371 [TBL] [Abstract][Full Text] [Related]
20. Overactivated mitogen-activated protein kinase by anisomycin induces tau hyperphosphorylation. Wang Q; Zhang JY; Liu SJ; Li HL Sheng Li Xue Bao; 2008 Aug; 60(4):485-91. PubMed ID: 18690390 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]